State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2

State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2

Bibliographic Details
Main Authors: J. Francis Borgio, Hind Saleh Alsuwat, Waad Mohammed Al Otaibi, Abdallah M. Ibrahim, Noor Almandil, Lubna Ibrahim Al Asoom, Mohammed Salahuddin, Balu Kamaraj, Sayed AbdulAzeez
Format: Article
Language:English
Published: Termedia Publishing House 2020-04-01
Series:Archives of Medical Science
Subjects:
covid-19
sars-cov-2
clinically approved drugs
molecular docking
helicase
antiretroviral agents
Online Access:https://www.termedia.pl/State-of-the-art-tools-unveil-potent-drug-targets-amongst-clinically-approved-drugs-to-inhibit-helicase-in-SARS-CoV-2,19,40407,1,1.html

Internet

https://www.termedia.pl/State-of-the-art-tools-unveil-potent-drug-targets-amongst-clinically-approved-drugs-to-inhibit-helicase-in-SARS-CoV-2,19,40407,1,1.html

Similar Items